Detalles de la búsqueda
1.
An atlas of healthy and injured cell states and niches in the human kidney.
Nature;
619(7970): 585-594, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468583
2.
Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
N Engl J Med;
390(13): 1196-1206, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598574
3.
Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
Circulation;
147(4): 310-323, 2023 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533535
4.
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
Ann Intern Med;
176(1): 59-66, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36469914
5.
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
J Am Soc Nephrol;
34(12): 1965-1975, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876229
6.
Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
Am J Kidney Dis;
81(1): 36-47, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868537
7.
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD.
J Am Soc Nephrol;
33(11): 2094-2107, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977807
8.
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Diabetologia;
65(7): 1085-1097, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35445820
9.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Kidney Int;
101(1): 174-184, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560136
10.
Assessment of a modified renal angina index for AKI prediction in critically ill adults.
Nephrol Dial Transplant;
37(5): 895-903, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33605426
11.
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.
Nephrol Dial Transplant;
37(9): 1647-1656, 2022 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850160
12.
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.
Diabetes Obes Metab;
24(5): 827-837, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984791
13.
Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes.
Crit Care;
26(1): 107, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422004
14.
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
J Am Soc Nephrol;
32(9): 2352-2361, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272327
15.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Eur Heart J;
42(13): 1216-1227, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792669
16.
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
Kidney Int;
100(1): 215-224, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878338
17.
Rationale and design of the Kidney Precision Medicine Project.
Kidney Int;
99(3): 498-510, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33637194
18.
Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study.
Crit Care;
25(1): 294, 2021 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391450
19.
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
Circulation;
139(3): 351-361, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30586723
20.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Nephrol Dial Transplant;
35(10): 1700-1711, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862232